A001630 Stock Overview
Manufactures and distributes pharmaceutical products in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Chong Kun Dang Holdings Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩48,750.00 |
| 52 Week High | ₩64,300.00 |
| 52 Week Low | ₩47,150.00 |
| Beta | 0.59 |
| 1 Month Change | -4.97% |
| 3 Month Change | -17.37% |
| 1 Year Change | -17.65% |
| 3 Year Change | -36.27% |
| 5 Year Change | -50.15% |
| Change since IPO | 58.89% |
Recent News & Updates
We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings
Nov 26
Why Investors Shouldn't Be Surprised By Chong Kun Dang Holdings Corp.'s (KRX:001630) Low P/E
Nov 14Benign Growth For Chong Kun Dang Holdings Corp. (KRX:001630) Underpins Its Share Price
Aug 06We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings
Mar 27Recent updates
We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings
Nov 26Why Investors Shouldn't Be Surprised By Chong Kun Dang Holdings Corp.'s (KRX:001630) Low P/E
Nov 14Benign Growth For Chong Kun Dang Holdings Corp. (KRX:001630) Underpins Its Share Price
Aug 06We Think That There Are Some Issues For Chong Kun Dang Holdings (KRX:001630) Beyond Its Promising Earnings
Mar 27Here's Why Chong Kun Dang Holdings (KRX:001630) Has A Meaningful Debt Burden
Apr 28Could Chong Kun Dang Holdings Corp. (KRX:001630) Have The Makings Of Another Dividend Aristocrat?
Apr 08Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Is An Interesting Stock
Mar 01The Chong Kun Dang Holdings (KRX:001630) Share Price Has Gained 54% And Shareholders Are Hoping For More
Feb 14Is Weakness In Chong Kun Dang Holdings Corp. (KRX:001630) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Feb 01Chong Kun Dang Holdings (KRX:001630) Has A Pretty Healthy Balance Sheet
Jan 19Should Chong Kun Dang Holdings Corp. (KRX:001630) Be Part Of Your Dividend Portfolio?
Jan 06
Do Institutions Own Chong Kun Dang Holdings Corp. (KRX:001630) Shares?
Dec 24Chong Kun Dang Holdings's (KRX:001630) Earnings Are Growing But Is There More To The Story?
Dec 11Here's Why I Think Chong Kun Dang Holdings (KRX:001630) Might Deserve Your Attention Today
Nov 28Shareholder Returns
| A001630 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.5% | 2.3% | -0.5% |
| 1Y | -17.7% | -1.0% | -11.6% |
Return vs Industry: A001630 underperformed the KR Pharmaceuticals industry which returned -1% over the past year.
Return vs Market: A001630 underperformed the KR Market which returned -11.6% over the past year.
Price Volatility
| A001630 volatility | |
|---|---|
| A001630 Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A001630 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A001630's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 37 | n/a | www.ckd-holdings.com/company/summary.do |
Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. The company was founded in 1941 and is based in Seoul, South Korea.
Chong Kun Dang Holdings Corp. Fundamentals Summary
| A001630 fundamental statistics | |
|---|---|
| Market cap | ₩232.08b |
| Earnings (TTM) | ₩41.53b |
| Revenue (TTM) | ₩955.30b |
5.6x
P/E Ratio0.2x
P/S RatioIs A001630 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A001630 income statement (TTM) | |
|---|---|
| Revenue | ₩955.30b |
| Cost of Revenue | ₩520.40b |
| Gross Profit | ₩434.90b |
| Other Expenses | ₩393.37b |
| Earnings | ₩41.53b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.72k |
| Gross Margin | 45.53% |
| Net Profit Margin | 4.35% |
| Debt/Equity Ratio | 56.3% |
How did A001630 perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield16%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 01:53 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chong Kun Dang Holdings Corp. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hye Mi Kim | Cape Investment & Securities Co., Ltd. |
| Kyung-rae Han | Daishin Securities Co. Ltd. |
| Jin Kyun Lim | IBK Securities Co. Ltd. |